The relationship between dose and antihypertensive effect for different AT₁-receptor blockersHANSSON, Lennart.Blood pressure. 2001, Vol 10, pp 33-39, issn 0803-7051, SUP3Conference Paper

How far should we lower blood pressure in the elderly : Hypertension in the elderlyHANSSON, Lennart.Cardiovascular drugs and therapy. 2001, Vol 15, Num 3, pp 275-279, issn 0920-3206Article

AT¹-receptor blocker in the management of hypertension - Differences that matterHANSSON, Lennart.Blood pressure. 2001, Vol 10, issn 0803-7051, 39 p., SUP3Conference Proceedings

Hypertension management in 2002: Where have we been? where might we be going?HANSSON, Lennart.American journal of hypertension. 2002, Vol 15, Num 10, pp 101S-107S, issn 0895-7061, 2Article

Mammal movements and foraging at remnant woodlands inside coniferous forest landscapesHANSSON, Lennart.Forest ecology and management. 2002, Vol 160, Num 1-3, pp 109-114, issn 0378-1127Article

Patient satisfaction in hypertension - evolving concepts. Meeting of international hypertension experts, London, 1996HANSSON, Lennart.Blood pressure. 1997, issn 0803-7051, 55 p., SUP1Serial Issue

Sustained Release Formulations in Hypertension: Pharmacokinetic Innovations with Indapamide SR 1.5mg and Related Clinical Implications. A Seminar-in-PrintHANSSON, Lennart.Clinical pharmacokinetics. 1999, Vol 37, issn 0312-5963, 42 p., SUP1Serial Issue

Dynamics and trophic interactions of small rodents: landscape or regional effects on spatial variation?HANSSON, Lennart.Oecologia. 2002, Vol 130, Num 2, pp 259-266, issn 0029-8549Article

Hypertension control for a new era: emerging differences among AIIRAsHANSSON, Lennart.Blood pressure. 2001, Vol 10, issn 0803-7051, 31 p., SUP2Conference Proceedings

Antihypertensive treatment: prevention of cardiovascular disease and prevention of events. Satellite symposiumHANSSON, Lennart.Journal of cardiovascular pharmacology. 1992, Vol 19, issn 0160-2446, 108 p., SUP3Conference Proceedings

Clinical comparative trials of angiotensin II type 1 (AT₁)-Receptor blockersMEREDITH, Peter A.Blood pressure. 2001, Vol 10, pp 11-17, issn 0803-7051, SUP3Conference Paper

AT₁-receptor blocker-based combination therapy in hypertensionTRENKWALDER, Peter.Blood pressure. 2001, Vol 10, pp 18-25, issn 0803-7051, SUP3Conference Paper

Vascular mechanisms in hypertensive cerebrovascular diseaseJOHANSSON, B. B.Journal of cardiovascular pharmacology. 1992, Vol 19, pp S11-S15, issn 0160-2446, SUP3Conference Paper

Has antihypertensive treatment prevented vascular disease or vascular events?ZANCHETTI, A.Journal of cardiovascular pharmacology. 1992, Vol 19, pp S1-S5, issn 0160-2446, SUP3Conference Paper

Role of calcium and endothelium in hypertension, cardiovascular disease, and subsequent vascular eventsVANHOUTTE, P. M.Journal of cardiovascular pharmacology. 1992, Vol 19, pp S6-S10, issn 0160-2446, SUP3Conference Paper

Clinical implications of indapamide sustained release 1.5mg in hypertensionDONNELLY, R.Clinical pharmacokinetics. 1999, Vol 37, pp 21-32, issn 0312-5963, SUP1Article

Pharmacology of AT₁-receptor blockersUNGER, Thomas.Blood pressure. 2001, Vol 10, pp 5-10, issn 0803-7051, SUP3Conference Paper

Concluding remarks: Pursuit of the optimal outcome in hypertensionHANSSON, L.Clinical pharmacokinetics. 1999, Vol 37, pp 33-38, issn 0312-5963, SUP1Article

Platelet activation by low-density lipoprotein and serotonin: effects of calcium antagonistsFETKOVSKA, N.Journal of cardiovascular pharmacology. 1992, Vol 19, pp S25-S28, issn 0160-2446, SUP3Conference Paper

Sympathetic Nervous System: The Link Between Heart Failure, Hypertension, and NIDDMHANSSON, Lennart; MANCIA, Giuseppe.Blood pressure. 1998, Vol 7, issn 0803-7051, 45 p., SUP3Conference Proceedings

Calcium antagonists : hypertension, atherosclerosis, and stroke, Milan, Italy, June 18, 1989HANSSON, LENNART; LARAGH, JOHN H.Journal of cardiovascular pharmacology. 1990, Vol 15, issn 0160-2446, 101 p., suppl. 1Conference Proceedings

Noninvasive imaging protocols to detect and monitor carotid atherosclerosis progressionMERCURI, M.American journal of hypertension. 1994, Vol 7, Num 7, pp 23S-29S, issn 0895-7061, 2Conference Paper

Antiatherosclerotic actions of isradipineSINZINGER, H; FITSCHA, P.Journal of cardiovascular pharmacology. 1992, Vol 19, pp S29-S31, issn 0160-2446, SUP3Conference Paper

Evaluation of end-points in hypertensionHANSSON, Lennart; MANCIA, Giuseppe.Blood pressure. 1997, issn 0803-7051, 123 p., SUP2Conference Proceedings

Myogenic mechanisms in the control of systemic resistance, 5-7 march 1989, MadeiraFOLKOW, Björn; HANSSON, Lennart; JOHANSSON, Börje et al.Journal of hypertension. 1989, Vol 7, issn 0263-6352, 4 p. non paginées, S1-S173 [177 p.], suppl. 4Conference Proceedings